Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers

Zhaomin Li, Zizheng Dong, David Myer, Michele Yip-Schneider, Jianguo Liu, Ping Cui, C. Schmidt, Jian-Ting Zhang

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3σ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis.Methods: Western blot analysis was used to determine 14-3-3σ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3σ was established and the effect of 14-3-3σ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays.Results: We found that 14-3-3σ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3σ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3σ in a pancreatic cancer cell line caused resistance to γ-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest.Conclusion: The increased level of 14-3-3σ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3σ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.

Original languageEnglish
Article number598
JournalBMC Cancer
Volume10
DOIs
StatePublished - Nov 1 2010

Fingerprint

Pancreatic Neoplasms
Drug Resistance
Radiation
14-3-3 Proteins
Apoptosis
Cell Line
Propidium
Testicular Neoplasms
Treatment Failure
Pharmaceutical Preparations
Cause of Death
Neoplasms
Cell Cycle
Therapeutics
Lymph Nodes
Western Blotting
Staining and Labeling
Neoplasm Metastasis
Messenger RNA
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics

Cite this

Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers. / Li, Zhaomin; Dong, Zizheng; Myer, David; Yip-Schneider, Michele; Liu, Jianguo; Cui, Ping; Schmidt, C.; Zhang, Jian-Ting.

In: BMC Cancer, Vol. 10, 598, 01.11.2010.

Research output: Contribution to journalArticle

Li, Zhaomin ; Dong, Zizheng ; Myer, David ; Yip-Schneider, Michele ; Liu, Jianguo ; Cui, Ping ; Schmidt, C. ; Zhang, Jian-Ting. / Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers. In: BMC Cancer. 2010 ; Vol. 10.
@article{e0a5ca6e289d4a2bb6cec57776ba4b6b,
title = "Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers",
abstract = "Background: Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90{\%} of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3σ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis.Methods: Western blot analysis was used to determine 14-3-3σ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3σ was established and the effect of 14-3-3σ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays.Results: We found that 14-3-3σ protein level was increased significantly in about 71{\%} (17 of 24) of human pancreatic cancer tissues and that the 14-3-3σ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3σ in a pancreatic cancer cell line caused resistance to γ-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest.Conclusion: The increased level of 14-3-3σ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3σ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.",
author = "Zhaomin Li and Zizheng Dong and David Myer and Michele Yip-Schneider and Jianguo Liu and Ping Cui and C. Schmidt and Jian-Ting Zhang",
year = "2010",
month = "11",
day = "1",
doi = "10.1186/1471-2407-10-598",
language = "English",
volume = "10",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers

AU - Li, Zhaomin

AU - Dong, Zizheng

AU - Myer, David

AU - Yip-Schneider, Michele

AU - Liu, Jianguo

AU - Cui, Ping

AU - Schmidt, C.

AU - Zhang, Jian-Ting

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Background: Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3σ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis.Methods: Western blot analysis was used to determine 14-3-3σ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3σ was established and the effect of 14-3-3σ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays.Results: We found that 14-3-3σ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3σ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3σ in a pancreatic cancer cell line caused resistance to γ-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest.Conclusion: The increased level of 14-3-3σ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3σ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.

AB - Background: Pancreatic cancer is the fourth leading cause of death in the US. Unlike other solid tumors such as testicular cancer which are now curable, more than 90% of pancreatic cancer patients die due to lack of response to therapy. Recently, the level of 14-3-3σ mRNA was found to be increased in pancreatic cancers and this increased expression may contribute to the failure in treatment of pancreatic cancers. In the present study, we tested this hypothesis.Methods: Western blot analysis was used to determine 14-3-3σ protein level in fresh frozen tissues and was correlated to clinical outcome. A stable cell line expressing 14-3-3σ was established and the effect of 14-3-3σ over-expression on cellular response to radiation and anticancer drugs were tested using SRB assay and clonogenic assays. Cell cycle distribution and apoptosis analyses were performed using propidium iodide staining and PARP cleavage assays.Results: We found that 14-3-3σ protein level was increased significantly in about 71% (17 of 24) of human pancreatic cancer tissues and that the 14-3-3σ protein level in cancers correlated with lymph node metastasis and poor prognosis. Furthermore, we demonstrated that over-expression of 14-3-3σ in a pancreatic cancer cell line caused resistance to γ-irradiation as well as anticancer drugs by causing resistance to treatment-induced apoptosis and G2/M arrest.Conclusion: The increased level of 14-3-3σ protein likely contributes to the poor clinical outcome of human pancreatic cancers by causing resistance to radiation and anticancer drugs. Thus, 14-3-3σ may serve as a prognosis marker predicting survival of pancreatic cancer patients and guide the clinical treatment of these patients.

UR - http://www.scopus.com/inward/record.url?scp=77958520728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958520728&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-10-598

DO - 10.1186/1471-2407-10-598

M3 - Article

C2 - 21040574

AN - SCOPUS:77958520728

VL - 10

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 598

ER -